Brainstorm Cell Therapeutics Inc.
BCLI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$2,106 | -$2,903 | -$2,864 | -$2,973 |
| Dep. & Amort. | $48 | $51 | $52 | $53 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $157 | $503 | $717 | $0 |
| Change in WC | $799 | -$1,153 | $643 | $1,946 |
| Other Non-Cash | $0 | $0 | -$179 | -$74 |
| Operating Cash Flow | -$1,102 | -$3,502 | -$1,631 | -$1,048 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $12 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $12 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$1,099 | $900 | $0 |
| Stock Issued | $313 | $3,350 | $685 | $1,058 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $450 | $1,501 | $0 |
| Financing Cash Flow | $313 | $2,701 | $3,086 | $1,058 |
| Forex Effect | $0 | $0 | $0 | -$3 |
| Net Chg. in Cash | -$789 | -$801 | $1,455 | $19 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,025 | $1,826 | $371 | $168 |
| End Cash | $236 | $1,025 | $1,826 | $187 |
| Free Cash Flow | -$1,102 | -$3,502 | -$1,631 | -$1,048 |